These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
398 related articles for article (PubMed ID: 30306212)
1. The Janus face of HMGB1 in heart disease: a necessary update. Raucci A; Di Maggio S; Scavello F; D'Ambrosio A; Bianchi ME; Capogrossi MC Cell Mol Life Sci; 2019 Jan; 76(2):211-229. PubMed ID: 30306212 [TBL] [Abstract][Full Text] [Related]
2. High Mobility Group Box 1 and Cardiovascular Diseases: Study of Act and Connect. Wasim R; Singh A; Islam A; Mohammed S; Anwar A; Mahmood T Cardiovasc Toxicol; 2024 Nov; 24(11):1268-1286. PubMed ID: 39242448 [TBL] [Abstract][Full Text] [Related]
3. HMGB1 and repair: focus on the heart. Pellegrini L; Foglio E; Pontemezzo E; Germani A; Russo MA; Limana F Pharmacol Ther; 2019 Apr; 196():160-182. PubMed ID: 30529040 [TBL] [Abstract][Full Text] [Related]
4. HMGB1-Mediated Activation of the Inflammatory-Reparative Response Following Myocardial Infarction. Foglio E; Pellegrini L; Russo MA; Limana F Cells; 2022 Jan; 11(2):. PubMed ID: 35053332 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of high mobility group box-1 in ischemic injury and tissue regeneration. Biscetti F; Ghirlanda G; Flex A Curr Vasc Pharmacol; 2011 Nov; 9(6):677-81. PubMed ID: 21692740 [TBL] [Abstract][Full Text] [Related]
6. High Mobility Group Box 1: Biological Functions and Relevance in Oxidative Stress Related Chronic Diseases. Taverna S; Tonacci A; Ferraro M; Cammarata G; Cuttitta G; Bucchieri S; Pace E; Gangemi S Cells; 2022 Mar; 11(5):. PubMed ID: 35269471 [TBL] [Abstract][Full Text] [Related]
7. Differential Regulation of Damage-Associated Molecular Pattern Release in a Mouse Model of Skeletal Muscle Ischemia/Reperfusion Injury. Furubeppu H; Ito T; Kakuuchi M; Yasuda T; Kamikokuryo C; Yamada S; Maruyama I; Kakihana Y Front Immunol; 2021; 12():628822. PubMed ID: 34381442 [TBL] [Abstract][Full Text] [Related]
8. Peroxynitrite induces HMGB1 release by cardiac cells in vitro and HMGB1 upregulation in the infarcted myocardium in vivo. Loukili N; Rosenblatt-Velin N; Li J; Clerc S; Pacher P; Feihl F; Waeber B; Liaudet L Cardiovasc Res; 2011 Feb; 89(3):586-94. PubMed ID: 21113057 [TBL] [Abstract][Full Text] [Related]
9. TLR9 is essential for HMGB1-mediated post-myocardial infarction tissue repair through affecting apoptosis, cardiac healing, and angiogenesis. Liu FY; Fan D; Yang Z; Tang N; Guo Z; Ma SQ; Ma ZG; Wu HM; Deng W; Tang QZ Cell Death Dis; 2019 Jun; 10(7):480. PubMed ID: 31209243 [TBL] [Abstract][Full Text] [Related]
10. The Role of HMGB1, a Nuclear Damage-Associated Molecular Pattern Molecule, in the Pathogenesis of Lung Diseases. Wang M; Gauthier A; Daley L; Dial K; Wu J; Woo J; Lin M; Ashby C; Mantell LL Antioxid Redox Signal; 2019 Nov; 31(13):954-993. PubMed ID: 31184204 [No Abstract] [Full Text] [Related]
11. The Role of HMGB1 in Rheumatic Diseases. Dong Y; Ming B; Dong L Front Immunol; 2022; 13():815257. PubMed ID: 35250993 [TBL] [Abstract][Full Text] [Related]
12. High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells. Andersson U; Yang H; Harris H Semin Immunol; 2018 Aug; 38():40-48. PubMed ID: 29530410 [TBL] [Abstract][Full Text] [Related]
13. Non-oxidizable HMGB1 induces cardiac fibroblasts migration via CXCR4 in a CXCL12-independent manner and worsens tissue remodeling after myocardial infarction. Di Maggio S; Milano G; De Marchis F; D'Ambrosio A; Bertolotti M; Palacios BS; Badi I; Sommariva E; Pompilio G; Capogrossi MC; Raucci A Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2693-2704. PubMed ID: 28716707 [TBL] [Abstract][Full Text] [Related]
14. HMGB1 as a therapeutic target in disease. Xue J; Suarez JS; Minaai M; Li S; Gaudino G; Pass HI; Carbone M; Yang H J Cell Physiol; 2021 May; 236(5):3406-3419. PubMed ID: 33107103 [TBL] [Abstract][Full Text] [Related]
15. Targeting Inflammation Driven by HMGB1. Yang H; Wang H; Andersson U Front Immunol; 2020; 11():484. PubMed ID: 32265930 [TBL] [Abstract][Full Text] [Related]
16. High-mobility group box 1, oxidative stress, and disease. Tang D; Kang R; Zeh HJ; Lotze MT Antioxid Redox Signal; 2011 Apr; 14(7):1315-35. PubMed ID: 20969478 [TBL] [Abstract][Full Text] [Related]
17. Critical role of RAGE and HMGB1 in inflammatory heart disease. Bangert A; Andrassy M; Müller AM; Bockstahler M; Fischer A; Volz CH; Leib C; Göser S; Korkmaz-Icöz S; Zittrich S; Jungmann A; Lasitschka F; Pfitzer G; Müller OJ; Katus HA; Kaya Z Proc Natl Acad Sci U S A; 2016 Jan; 113(2):E155-64. PubMed ID: 26715748 [TBL] [Abstract][Full Text] [Related]
18. Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Limana F; Germani A; Zacheo A; Kajstura J; Di Carlo A; Borsellino G; Leoni O; Palumbo R; Battistini L; Rastaldo R; Müller S; Pompilio G; Anversa P; Bianchi ME; Capogrossi MC Circ Res; 2005 Oct; 97(8):e73-83. PubMed ID: 16166556 [TBL] [Abstract][Full Text] [Related]
19. Modulated inflammation by injection of high-mobility group box 1 recovers post-infarction chronically failing heart. Takahashi K; Fukushima S; Yamahara K; Yashiro K; Shintani Y; Coppen SR; Salem HK; Brouilette SW; Yacoub MH; Suzuki K Circulation; 2008 Sep; 118(14 Suppl):S106-14. PubMed ID: 18824741 [TBL] [Abstract][Full Text] [Related]
20. Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling. Paudel YN; Angelopoulou E; Piperi C; Balasubramaniam VRMT; Othman I; Shaikh MF Eur J Pharmacol; 2019 Sep; 858():172487. PubMed ID: 31229535 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]